background
hospit
admiss
patient
suspect
infect
influenza
respiratori
syncyti
viru
rsv
place
isol
pend
outcom
diagnost
signific
number
isol
care
prove
unnecessari
investig
potenti
impact
molecular
pointofcar
poc
diagnost
patient
manag
inhospit
cost
method
prospect
collect
data
resourc
util
within
hospit
consecut
patient
year
older
present
univers
medic
center
symptom
respiratori
tract
infect
decemb
april
cost
analysi
conduct
use
markov
model
compar
actual
cours
event
basi
routin
diagnost
test
two
hypothet
scenario
poc
would
impact
time
diagnosi
scenario
discharg
hospit
scenario
result
total
patient
includ
admit
influenza
rsv
detect
patient
respect
fiftyfour
percent
patient
test
neg
kept
isol
care
wait
test
result
median
durat
hour
median
length
stay
day
mean
total
inhospit
cost
per
patient
introduc
poc
would
lower
mean
cost
per
patient
scenario
scenario
hospit
level
would
result
total
cost
reduct
singl
influenza
season
conclus
introduc
poc
test
patient
present
symptom
viral
respiratori
tract
infect
reduc
timetodiagnosi
hospit
stay
therebi
inhospit
cost
singleperson
room
avail
multipleperson
room
may
use
singl
patient
result
loss
admiss
capac
highli
impact
hospit
resourc
util
healthcar
cost
furthermor
clinic
uncertainti
caus
diseas
viral
versu
bacteri
mani
patient
treat
empir
nontarget
antibiot
therapi
result
microbiolog
diagnost
known
wherea
actual
need
rapid
detect
respiratori
viral
pathogen
therefor
also
potenti
reduc
durat
empir
start
antibiot
initi
appropri
antivir
treatment
antivir
treatment
influenza
start
within
hour
onset
diseas
effect
aim
studi
assess
potenti
impact
poc
test
influenza
rsv
patient
manag
associ
hospit
cost
decemb
april
patient
age
year
older
suspicion
respiratori
viral
infect
includ
either
admit
hospit
ambulatori
hospit
tertiari
referr
academ
center
netherland
respiratori
sampl
taken
basi
clinic
judgment
physician
patient
characterist
collect
sex
age
underli
ill
length
hospit
stay
admiss
icu
mortal
respiratori
sampl
divid
two
aliquot
one
routin
laboratori
molecular
test
one
coba
liat
system
aliquot
coba
liat
system
store
minu
retrospect
test
end
studi
patient
follow
collect
data
resourc
util
within
hospit
time
final
diagnosi
discharg
time
admiss
time
collect
respiratori
materi
time
spent
isol
respiratori
ill
time
arriv
specimen
laboratori
time
result
diagnost
test
data
antimicrobi
retriev
electron
patient
record
system
laboratori
inform
system
routin
detect
influenza
viru
rsv
diagenod
assay
perform
describ
templeton
et
al
test
coba
liat
influenzarsv
assay
carri
accord
manufactur
instruct
requir
patient
sampl
pipet
suppli
assay
tube
test
coba
liat
analyz
markov
decis
model
develop
compar
cost
three
scenario
actual
clinic
manag
compar
two
hypothet
scenario
clinic
manag
would
base
coba
liat
poc
hypothet
scenario
correct
diagnosi
assum
made
within
hour
upon
admiss
one
scenario
impact
reduc
timetodiagnosi
inhospit
resourc
util
associ
cost
model
scenario
wherea
second
model
took
account
reduc
hospit
stay
well
scenario
patient
present
outpati
clinic
distinguish
present
emerg
depart
markov
model
construct
reflect
inhospit
rout
patient
distinguish
seven
specif
state
figur
scenario
patient
start
outpati
clinic
emerg
depart
state
could
either
remain
state
discharg
ie
hospit
state
could
hospit
isol
care
state
state
case
infect
statu
unknown
state
could
either
remain
state
progress
state
isol
care
infecti
state
establishedne
isol
care
confirm
state
progress
state
isol
care
infecti
state
establishedne
isol
care
disconfirm
ie
influenza
rsv
detect
state
progress
state
isol
care
infecti
state
known
absenc
isol
confirm
state
hospit
isol
care
infecti
state
unknown
patient
could
remain
state
progress
state
patient
state
could
remain
state
progress
state
discharg
hospit
addit
patient
state
could
progress
state
cost
routin
poc
diagnost
test
basi
estim
cost
price
assay
avail
standard
cost
price
basi
nation
guidelin
use
calcul
mean
cost
per
patient
cost
admiss
isol
care
assum
twice
cost
nonisol
admiss
would
reflect
addit
protect
equip
patient
personnel
use
oneperson
room
multipl
room
occup
singl
patient
extra
workload
staff
eg
need
find
capac
within
hospit
neighbor
hospit
loss
product
inabl
admit
patient
lack
capac
tabl
repres
overview
cost
use
model
analys
perform
use
treeag
pro
softwar
retrospect
test
use
coba
liat
influenzarsv
assay
possibl
patient
patient
either
result
use
coba
liat
assay
invalid
materi
left
retest
n
respiratori
materi
left
initi
routin
test
n
patient
test
influenza
influenza
b
rsv
posit
routin
pcr
compar
result
use
coba
liat
influenzarsv
assay
tabl
four
patient
test
neg
routin
pcr
turn
influenza
n
rsv
n
posit
use
coba
liat
influenzarsv
assay
one
patient
routin
pcr
sputum
neg
rsv
posit
subsequ
bal
materi
initi
sputum
posit
rsv
use
coba
liat
influenzarsv
assay
three
patient
respiratori
materi
avail
test
distinguish
true
fals
posit
find
use
coba
liat
influenzarsv
assay
result
markov
model
present
figur
compar
refer
scenario
scenario
repres
impact
poc
test
timetodiagnosi
figur
scenario
poc
test
also
impact
discharg
hospit
figur
cost
associ
inhospit
care
patient
suspect
influenza
rsv
infect
present
tabl
cost
estim
basi
averag
length
stay
patient
variou
model
state
combin
unit
cost
price
tabl
b
l
e
mean
durat
variou
model
state
hour
associ
cost
euro
per
patient
suspect
influenza
rsv
infect
case
care
usual
case
reduc
timetodiagnosi
result
poc
scenario
case
addit
impact
poc
length
stay
scenario
total
cost
confid
interv
present
basi
firstord
mont
carlo
simul
three
model
number
bracket
scenario
usual
care
mean
cost
per
patient
amount
introduc
poc
would
lower
inhospit
cost
scenario
respect
studi
suggest
introduc
poc
test
influenza
timeli
manner
two
random
studi
show
signific
reduct
turnaroundtim
posit
effect
time
prescript
antivir
therapi
howev
effect
observ
length
hospit
stay
antibiot
use
impact
poc
respiratori
viru
test
clinic
decis
make
patient
respiratori
symptom
emerg
depart
assess
two
recent
report
approxi
studi
financi
support
unrestrict
grant
roch
ltd
funder
role
studi
design
data
collect
interpret
decis
submit
work
public
